QIAGEN - 24 Year Stock Price History | QGEN

Historical daily share price chart and data for QIAGEN since 1996 adjusted for splits. The latest closing stock price for QIAGEN as of November 27, 2020 is 48.49.
  • The all-time high QIAGEN stock closing price was 59.58 on July 17, 2000.
  • The QIAGEN 52-week high stock price is 55.27, which is 14% above the current share price.
  • The QIAGEN 52-week low stock price is 30.23, which is 37.7% below the current share price.
  • The average QIAGEN stock price for the last 52 weeks is 43.67.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
QIAGEN Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 44.0015 33.9300 54.7400 33.1700 48.4900 43.46%
2019 37.0654 34.1300 43.1000 25.4100 33.8000 -1.89%
2018 35.1436 31.3600 39.3900 31.0100 34.4500 11.38%
2017 31.4871 29.3043 35.3700 27.8100 30.9300 6.30%
2016 25.1390 27.7362 29.7196 20.9657 29.0966 1.34%
2015 26.4008 24.2679 29.2939 23.1672 28.7124 17.86%
2014 23.9161 24.4341 26.1475 20.7788 24.3614 -1.47%
2013 21.6469 19.5016 25.5971 19.1589 24.7248 31.19%
2012 17.4977 14.7040 19.9377 14.7040 18.8471 31.42%
2011 17.9318 20.6127 22.8764 13.1360 14.3406 -29.36%
2010 21.1574 23.5306 24.9013 17.6739 20.3011 -12.45%
2009 19.5696 17.7674 24.0187 15.3998 23.1880 27.16%
2008 20.1349 22.5961 24.2887 13.4060 18.2347 -16.58%
2007 18.9263 16.2409 24.4548 15.9086 21.8588 39.13%
2006 14.8945 12.5026 16.7705 12.1703 15.7113 28.77%
2005 12.6613 11.4538 14.2991 10.9657 12.2015 7.31%
2004 12.0099 12.7934 16.2098 9.0758 11.3707 -8.44%
2003 9.1966 5.6906 13.3437 5.3998 12.4195 130.44%
2002 11.3741 19.7508 21.6096 4.6833 5.3894 -72.04%
2001 23.1759 36.3448 36.7394 12.8557 19.2731 -46.34%
2000 41.6231 21.2876 59.5846 19.5353 35.9190 83.26%
1999 11.2352 8.5021 21.6771 8.5021 19.6002 150.62%
1998 7.6377 5.8255 9.8650 5.4361 7.8206 35.03%
1997 5.2751 3.2944 7.6584 3.1477 5.7918 73.28%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $11.044B $1.526B
Qiagen NV produces biomedical and genetic products, products for separating and purifying nucleic acids for gene-based drug screening, nucleic acid-based clinical diagnostics, genetic vaccination and gene therapy.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $142.663B 10.17
Amgen (AMGN) United States $130.877B 13.68
CSL (CSLLY) Australia $102.723B 0.00
Gilead Sciences (GILD) United States $75.249B 10.01
Vertex Pharmaceuticals (VRTX) United States $58.953B 27.41
Regeneron Pharmaceuticals (REGN) United States $54.852B 19.46
Moderna (MRNA) United States $50.267B 0.00
Illumina (ILMN) United States $46.286B 63.66
Biogen (BIIB) United States $37.513B 6.66
Seagen (SGEN) United States $30.493B 80.53
Alexion Pharmaceuticals (ALXN) United States $27.100B 10.80
BeiGene (BGNE) Cayman Islands $25.958B 0.00
BioNTech SE (BNTX) Germany $24.887B 0.00
Genmab (GMAB) Denmark $24.337B 28.78
Genmab (GNMSF) Denmark $23.134B 5.33
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.638B 0.00
Incyte (INCY) United States $18.231B 0.00
Exact Sciences (EXAS) United States $17.779B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.674B 59.44
Horizon Therapeutics Public (HZNP) Ireland $15.571B 22.26
Alnylam Pharmaceuticals (ALNY) United States $15.087B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.595B 96.87
ARGENX SE-ADR (ARGX) Netherlands $13.237B 0.00
Guardant Health (GH) United States $11.863B 0.00
Mirati Therapeutics (MRTX) United States $11.692B 0.00
Bio-Techne Corp (TECH) United States $11.492B 73.49
Sarepta Therapeutics (SRPT) United States $10.981B 0.00
Repligen (RGEN) United States $9.839B 139.54
ACADIA Pharmaceuticals (ACAD) United States $8.903B 0.00
Ascendis Pharma (ASND) Denmark $8.788B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $8.588B 0.00
Galapagos (GLPG) Belgium $8.223B 0.00
Novavax (NVAX) United States $8.001B 0.00
Ultragenyx Pharmaceutical (RARE) United States $7.473B 0.00
Denali Therapeutics (DNLI) United States $7.347B 0.00
Acceleron Pharma (XLRN) United States $7.095B 0.00
Adaptive Biotechnologies (ADPT) United States $6.428B 0.00
Amicus Therapeutics (FOLD) United States $6.056B 0.00
Exelixis (EXEL) United States $6.022B 40.44
Blueprint Medicines (BPMC) United States $5.978B 19.79
Halozyme Therapeutics (HALO) United States $5.438B 251.44
SWEDISH ORP BIO (BIOVF) Sweden $5.355B 14.63
Reata Pharmaceuticals (RETA) United States $5.328B 0.00
NeoGenomics (NEO) United States $5.258B 1578.67
Twist Bioscience (TWST) United States $5.122B 0.00
Fate Therapeutics (FATE) United States $5.053B 0.00
China Biologic Products (CBPO) China $4.682B 30.34
Emergent Biosolutions (EBS) United States $4.390B 14.41
Insmed (INSM) United States $4.054B 0.00
Arena Pharmaceuticals (ARNA) United States $3.833B 0.00
Vir Biotechnology (VIR) United States $3.776B 0.00
Legend Biotech (LEGN) United States $3.748B 0.00
MorphoSys AG (MOR) Germany $3.706B 134.14
Deciphera Pharmaceuticals (DCPH) United States $3.550B 0.00
Eidos Therapeutics (EIDX) United States $3.480B 0.00
Alkermes (ALKS) Ireland $2.944B 28.91
Bluebird Bio (BLUE) United States $2.924B 0.00
Global Blood Therapeutics (GBT) United States $2.775B 0.00
Beam Therapeutics (BEAM) United States $2.763B 0.00
Seres Therapeutics (MCRB) United States $2.647B 0.00
Intellia Therapeutics (NTLA) United States $2.327B 0.00
Zymeworks (ZYME) Canada $2.285B 0.00
Viela Bio (VIE) United States $2.164B 0.00
Sorrento Therapeutics (SRNE) United States $2.143B 0.00
I-Mab (IMAB) China $2.127B 0.00
PHARMA MAR SA (PHMMF) Spain $2.120B 0.00
UniQure (QURE) Netherlands $2.102B 0.00
Inovio Pharmaceuticals (INO) United States $2.077B 0.00
Intra-Cellular Therapies (ITCI) United States $2.002B 0.00
Editas Medicine (EDIT) United States $1.954B 0.00
Alcobra (ARCT) United States $1.861B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.842B 0.00
Amarin (AMRN) Ireland $1.799B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.752B 0.00
Mesoblast (MESO) Australia $1.752B 0.00
Mersana Therapeutics (MRSN) United States $1.720B 0.00
Arcus Biosciences (RCUS) United States $1.669B 0.00
Revance Therapeutics (RVNC) United States $1.650B 0.00
NGM Biopharmaceuticals (NGM) United States $1.646B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.607B 13.30
Scholar Rock Holding (SRRK) United States $1.578B 0.00
Zealand Pharma (ZEAL) Denmark $1.497B 0.00
Sangamo Therapeutics (SGMO) United States $1.431B 0.00
Precigen (PGEN) United States $1.389B 0.00
REGENXBIO (RGNX) United States $1.386B 0.00
Ligand Pharmaceuticals (LGND) United States $1.382B 35.80
Adverum Biotechnologies (ADVM) United States $1.374B 0.00
Coherus BioSciences (CHRS) United States $1.342B 8.87
Myriad Genetics (MYGN) United States $1.337B 0.00
Athenex (ATNX) United States $1.300B 0.00
Zealand Pharma (ZLDPF) Denmark $1.287B 0.00
Epizyme (EPZM) United States $1.232B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.230B 0.00
Cytokineticsorporated (CYTK) United States $1.214B 0.00
Travere Therapeutics (TVTX) United States $1.214B 0.00
Genetron Holdings (GTH) China $1.213B 0.00
Heska (HSKA) United States $1.205B 0.00
Pliant Therapeutics (PLRX) United States $1.170B 0.00
Vericel (VCEL) United States $1.145B 0.00
Codexis (CDXS) United States $1.068B 0.00
Alector (ALEC) United States $1.053B 0.00
NantKwest (NK) United States $1.050B 0.00
Cellectis S.A (CLLS) France $1.029B 0.00
Arvinas (ARVN) United States $1.007B 0.00
Morphic Holding (MORF) United States $0.998B 0.00
Northwest Biotherapeutics (NWBO) United States $0.997B 0.00
Frequency Therapeutics (FREQ) United States $0.969B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.935B 0.00
Protagonist Therapeutics (PTGX) United States $0.912B 0.00
Celldex Therapeutics (CLDX) United States $0.900B 0.00
Compugen (CGEN) Israel $0.889B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.888B 0.00
Castle Biosciences (CSTL) United States $0.885B 0.00
Pharming Group (PHGUF) Netherlands $0.864B 19.71
Cardiff Oncology (CRDF) United States $0.774B 0.00
Cara Therapeutics (CARA) United States $0.745B 0.00
MiMedx (MDXG) United States $0.737B 0.00
Five Prime Therapeutics (FPRX) United States $0.725B 0.00
MannKind (MNKD) United States $0.716B 0.00
Kadmon Holdings (KDMN) United States $0.707B 0.00
Agenus (AGEN) United States $0.705B 0.00
AnaptysBio (ANAB) United States $0.705B 0.00
VBI Vaccines (VBIV) United States $0.702B 0.00
Albireo Pharma (ALBO) United States $0.693B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.679B 34.47
Sutro Biopharma (STRO) United States $0.660B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.653B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
Adaptimmune Therapeutics (ADAP) United Kingdom $0.639B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.638B 0.00
Precision BioSciences (DTIL) United States $0.626B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.624B 0.00
IVERIC Bio (ISEE) United States $0.593B 0.00
Geron (GERN) United States $0.581B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.563B 0.00
Anika Therapeutics (ANIK) United States $0.544B 73.60
MeiraGTx Holdings (MGTX) United States $0.534B 0.00
Dynavax Technologies (DVAX) United States $0.528B 0.00
Avid Bioservices (CDMO) United States $0.506B 0.00
Merus (MRUS) Netherlands $0.480B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.476B 0.00
Forte Biosciences (FBRX) United States $0.473B 0.00
Puma Biotechnology (PBYI) United States $0.466B 0.00
Spero Therapeutics (SPRO) United States $0.455B 0.00
WAVE Life Sciences (WVE) Singapore $0.452B 0.00
Prothena (PRTA) Ireland $0.451B 0.00
Innate Pharma S.A (IPHA) France $0.439B 0.00
Amryt Pharma (AMYT) United Kingdom $0.434B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.432B 0.00
UROGEN PHARMA (URGN) United States $0.428B 0.00
Clovis Oncology (CLVS) United States $0.420B 0.00
Cue Biopharma (CUE) United States $0.416B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.413B 0.00
Kala Pharmaceuticals (KALA) United States $0.409B 0.00
Starpharma Holdings (SPHRY) Australia $0.405B 0.00
Trevena (TRVN) United States $0.404B 0.00
Affimed (AFMD) Germany $0.403B 0.00
AC Immune SA (ACIU) Switzerland $0.400B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.399B 0.00
BioDelivery Sciences (BDSI) United States $0.386B 18.19
Athersys (ATHX) United States $0.376B 0.00
Syros Pharmaceuticals (SYRS) United States $0.373B 0.00
Selecta Biosciences (SELB) United States $0.369B 0.00
Arbutus Biopharma (ABUS) United States $0.369B 0.00
ANI Pharmaceuticals (ANIP) United States $0.364B 9.27
Cellular Biomedicine (CBMG) United States $0.364B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.362B 0.00
XOMA (XOMA) United States $0.353B 0.00
CytomX Therapeutics (CTMX) United States $0.343B 0.00
Verastem (VSTM) United States $0.338B 0.00
ChromaDex (CDXC) United States $0.310B 0.00
Kamada (KMDA) Israel $0.303B 14.17
PDL BioPharma (PDLI) United States $0.296B 0.00
NextCure (NXTC) United States $0.286B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.283B 0.00
DBV Technologies S.A (DBVT) France $0.280B 0.00
Fortress Biotech (FBIO) United States $0.260B 0.00
Pluristem Therapeutics (PSTI) Israel $0.246B 0.00
HOOKIPA Pharma (HOOK) United States $0.242B 0.00
Aptinyx (APTX) United States $0.241B 0.00
TELA Bio (TELA) United States $0.240B 0.00
GENFIT S.A (GNFT) France $0.210B 0.00
Eton Pharmaceuticals (ETON) United States $0.193B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.190B 0.00
Cerecor (CERC) United States $0.189B 0.00
AquaBounty Technologies (AQB) United States $0.187B 0.00
Strongbridge Biopharma (SBBP) United States $0.186B 0.00
POXEL SA FRANCE (PXXLF) France $0.185B 0.00
Bellus Health (BLU) Canada $0.184B 0.00
Aptevo Therapeutics (APVO) United States $0.184B 0.00
Theratechnologies (THTX) Canada $0.180B 0.00
ADMA Biologics Inc (ADMA) United States $0.180B 0.00
Nicox SA (NICXF) France $0.170B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.165B 0.00
Abeona Therapeutics (ABEO) United States $0.163B 0.00
Biofrontera AG (BFRA) Germany $0.162B 0.00
Checkpoint Therapeutics (CKPT) United States $0.161B 0.00
Dyadic (DYAI) United States $0.159B 0.00
VTv Therapeutics (VTVT) United States $0.159B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.158B 0.00
SESEN BIO, INC (SESN) United States $0.157B 0.00
Oncobiologics (OTLK) United States $0.156B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.156B 0.00
Kindred Biosciences (KIN) United States $0.154B 0.00
Idera Pharmaceuticals (IDRA) United States $0.151B 0.00
Exicure (XCUR) United States $0.140B 0.00
Celyad SA (CYAD) Belgium $0.139B 0.00
Catalyst Biosciences (CBIO) United States $0.131B 0.00
Cocrystal Pharma (COCP) United States $0.130B 0.00
Lumos Pharma (LUMO) United States $0.124B 0.00
Gritstone Oncology (GRTS) United States $0.123B 0.00
TRACON Pharmaceuticals (TCON) United States $0.121B 0.00
Antibe Therapeutics (ATBPF) Canada $0.120B 0.00
Orgenesis (ORGS) United States $0.120B 247.50
Aytu Bioscience (AYTU) United States $0.118B 0.00
Liquidia Technologies (LQDA) United States $0.114B 0.00
Windtree Therapeutics (WINT) United States $0.113B 0.00
Applied Genetic Technologies (AGTC) United States $0.112B 0.00
Cogent Biosciences (COGT) United States $0.111B 0.00
PhaseBio Pharaceuticals (PHAS) United States $0.111B 0.00
Cyclerion Therapeutics (CYCN) United States $0.111B 0.00
DiaMedica Therapeutics (DMAC) United States $0.108B 0.00
Cidara Therapeutics (CDTX) United States $0.102B 0.00
Prometic Life Sciences (LMNL) Canada $0.098B 0.00
Enzo Biochem (ENZ) United States $0.097B 0.00
Novogen (KZIA) Australia $0.096B 0.00
Clearside Biomedical (CLSD) United States $0.094B 0.00
AIT Therapeutics (XAIR) United States $0.091B 0.00
ARAVIVE, INC (ARAV) United States $0.091B 0.00
Ecology Coatings (ABVC) United States $0.087B 0.00
Synlogic (SYBX) United States $0.087B 0.00
Curis (CRIS) United States $0.085B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.077B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.076B 0.00
Evogene (EVGN) Israel $0.076B 0.00
Bionano Genomics (BNGO) United States $0.075B 0.00
Prima BioMed (IMMP) Australia $0.074B 0.00
AnPac Bio-Medical Science (ANPC) China $0.069B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.069B 0.00
Stealth BioTherapeutics (MITO) United States $0.068B 32.75
Adocia (ADOCY) France $0.067B 0.00
MiRagen Therapeutics (MGEN) United States $0.066B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.066B 0.00
Soligenix (SNGX) United States $0.065B 0.00
Appili Therapeutics (APLIF) Canada $0.061B 0.00
Organovo Holdings (ONVO) United States $0.061B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.060B 0.00
Emmaus Life Sciences (EMMA) United States $0.059B 0.00
Proteostasis Therapeutics (PTI) United States $0.057B 0.00
Seelos Therapeutics (SEEL) United States $0.055B 0.00
Vascular Biogenics (VBLT) Israel $0.053B 0.00
Happiness Biotech Group (HAPP) China $0.051B 0.00
Edesa Biotech (EDSA) Canada $0.050B 0.00
Vaccinex (VCNX) United States $0.047B 0.00
Cleveland BioLabs (CBLI) United States $0.047B 0.00
CollPlant Holdings (CLGN) Israel $0.045B 0.00
Pulmatrix (PULM) United States $0.044B 0.00
Genetic Technologies (GENE) Australia $0.043B 0.00
IMMURON (IMRN) Australia $0.041B 0.00
ATyr Pharma (LIFE) United States $0.036B 0.00
OvaScience (MLND) United States $0.036B 0.00
Chanticleer Holdings (SONN) United States $0.035B 0.00
Titan Pharmaceuticals (TTNP) United States $0.035B 0.00
Acorda Therapeutics (ACOR) United States $0.033B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.032B 0.00
BioCardia (BCDA) United States $0.029B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.027B 0.00
AEterna Zentaris (AEZS) United States $0.026B 0.00
Alimera Sciences (ALIM) United States $0.024B 0.00
Prana Biotechnology (ATHE) Australia $0.023B 0.00
Celsion (CLSN) United States $0.021B 0.00
Cesca Therapeutics (THMO) United States $0.020B 0.00
Advaxis (ADXS) United States $0.019B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.019B 0.00
Spherix (AIKI) United States $0.018B 0.00
Invo BioScience (INVO) United States $0.016B 0.00
Neuralstem (SNCA) United States $0.010B 0.00
GeoVax Labs (GOVX) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.003B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Osmotica Pharmaceuticals (OSMT) United States $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00